Global Pharmaceutical Grade Lactose Market Report and Forecast 2024-2032

Global Pharmaceutical Grade Lactose Market Outlook

The global Pharmaceutical Grade Lactose market size was approximately USD 1.92 billion in 2023. The market is projected to grow at a CAGR of 7.2% between 2024 and 2032, reaching a value of around USD 3.63 billion by 2032.

Key Trends in the Market

Lactose, a sugar present in milk, comprises glucose and galactose. The enzyme, lactase, aids its breakdown in the small intestine. Insufficient lactase leads to undigested lactose, causing symptoms like bloating and diarrhoea.

In the pharmaceutical industry, lactose is a common excipient, present in over 20% of prescription medicines and 6% of over-the-counter drugs. Its functions as a flow agent, binder, and disintegrant make it valuable in various formulations like tablets, capsules, and oral solutions, enhancing pharmaceutical product quality and safety.

• Rising global investments in the healthcare sector are expected to strengthen the global pharmaceutical grade lactose market growth in the coming years. In the pharmaceutical industry, lactose is widely used as a filler to provide bulk for instance tablets, offer flow to a formulation, and as a binder to keep formulas together.

• The healthcare sector witnesses numerous companies vying for market share, delivering products to diverse end-users on a global scale. The increasing attempts by companies to gain a competitive edge through strategic product launches, expansions, and dedicated research and development initiatives are aiding the pharmaceutical grade lactose market demand globally.

• Increasing awareness of the benefits associated with pharmaceutical-grade lactose products and the rising recognition of the significance of infant nutrition are pivotal factors propelling market growth.

Pharmaceutical Grade Lactose Market Segmentation

Based on type, the market is categorised into crystalline monohydrate lactose, inhalation lactose, granulated lactose, and spray-dried lactose, among others. The major regional markets for Pharmaceutical Grade Lactose are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter’s five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global pharmaceutical grade lactose market, covering their competitive landscape and the latest developments like mergers, acquisitions, investments, and expansion plans.

• DFE Pharma GmbH & Co KG

• Fengchen Group Co.,Ltd

• Lactalis International

• ALPAVIT

• Kavya Pharma 

• MEGGLE GmbH & Co. KG 

• Surfachem Group Ltd. 

• Others

Market Share by Type

As per the pharmaceutical grade lactose market analysis, crystalline monohydrate lactose secured a notable revenue share in the historical period. This can be attributed to its high purity, solubility, and flow properties, making it a preferred choice for manufacturers focused on ensuring the safety and efficacy of their pharmaceutical products.

Specifically formulated for dry powder inhalers (DPIs), inhalation lactose serves as a carrier for active pharmaceutical ingredients (APIs). Manufactured through a comprehensive process involving spray drying and sieving, the lactose particles in DPIs typically range from 15 to 90 microns, facilitating efficient delivery of inhaler medicine to the lungs.

In the pharmaceutical industry, spray-dried lactose is employed as a filler or carrier, produced by atomising a lactose solution into a hot air stream. This process evaporates the solvent, yielding dry lactose particles in the 10–200 micron range with high surface area and porosity, making them excellent carriers for active ingredients.

Market Share by Region

North America held a significant revenue of the overall pharmaceutical grade lactose market share in the historical period, driven by the presence of established players like Pfizer, Johnson & Johnson, and Merck. The adoption of lactose-induced infant formula in the region has shown benefits such as improved digestion and prevention of gastrointestinal issues in infants, fostering increasing awareness among healthcare providers and parents.

In the Asia Pacific, government initiatives promoting the affordability of prescription drugs and encouraging foreign investments contribute to the market growth. The region’s distinctive landscape features numerous small-scale players with in-line manufacturing capabilities, contributing to anticipated significant growth over the forecast period.

Meanwhile, Europe witnesses a flourishing pharmaceutical industry due to a growing ageing population, resulting in heightened demand for medicines and healthcare services. The region boasts a robust foundation for research and development, with universities, research centres, and biotech companies driving innovation and new drug development. The European Union (EU) has implemented regulations and incentives to bolster the market growth and attract investments, further fuelling demand for the product, primarily used in tablets and capsules.

Competitive Landscape

Lactalis International, established in 1933 and based in Laval, France, is a dairy products provider. Some of its well-known dairy products are butter, cheese, cream, yoghurt, and baby formulas. The company’s leading international brands include Ambassador, Bridel, Galbani, Lactel, and Santal, among others.

MEGGLE GmbH & Co. KG, founded in 1887, is a milk and whey corporation, headquartered in Wasserburg am Inn, Germany. It primarily offers its products and services in the sectors of food, feed, and pharmaceutical. The company complies with GMP (good manufacturing practice) regulations, which are a necessity to supply inactive substances such as lactose to the pharmaceutical sector.

DFE Pharma GmbH & Co KG, a global leader in pharmaceutical excipient solutions, leverages over a century of experience and a workforce of 400+ individuals across 100+ countries. Headquartered in Goch, Germany, the company serves 5,000+ customers, providing high-quality functional excipients for the pharmaceutical, biopharmaceutical, and nutraceutical industries. DFE Pharma is dedicated to enhancing patients' lives by delivering reliable solutions in respiratory, oral solid dose, ophthalmic, and parenteral formulations.

Other pharmaceutical grade lactose market players include Fengchen Group Co.,Ltd, ALPAVIT, Kavya Pharma, and Surfachem Group Ltd., among others.

Key Highlights of the Report